{"id":3707,"date":"2022-08-23T12:26:40","date_gmt":"2022-08-23T10:26:40","guid":{"rendered":"https:\/\/www.cvs-avocats.com\/pratiques-anticoncurrentielles-domaine-medicament\/"},"modified":"2025-03-03T16:42:20","modified_gmt":"2025-03-03T15:42:20","slug":"pratiques-anticoncurrentielles-domaine-medicament","status":"publish","type":"post","link":"https:\/\/www.cvs-avocats.com\/fr\/pratiques-anticoncurrentielles-domaine-medicament\/","title":{"rendered":"Pratiques anticoncurrentielles dans le domaine du m\u00e9dicament"},"content":{"rendered":"<div class=\"section__body\">\n<div class=\"block-strong-text\">\n<p>Afin d\u2019obtenir une\u00a0Autorisation de Mise sur le March\u00e9 (AMM)\u00a0pour un m\u00e9dicament en France, un laboratoire pharmaceutique doit pr\u00e9senter un dossier aupr\u00e8s de l\u2019ANSM\u00a0pr\u00e9sentant notamment diff\u00e9rentes donn\u00e9es cliniques.<\/p>\n<\/div>\n<article class=\"article-normal\">\n<div class=\"article__entry\">\n<p>Lorsqu\u2019un laboratoire pharmaceutique fran\u00e7ais ou \u00e9tranger souhaite obtenir une AMM pour un m\u00e9dicament g\u00e9n\u00e9rique, le dossier doit \u00e9galement comporter des \u00e9tudes de bio\u00e9quivalence avec le princeps.<\/p>\n<\/div>\n<\/article>\n<ul class=\"list-icons\">\n<li><a href=\"https:\/\/www.eurojuris.fr\/accueil\/articles\/pratiques-anticoncurrentielles-domaine-medicament-41074.htm\">Retrouvez l&rsquo;article d&rsquo;EuroJuris<\/a><\/li>\n<\/ul>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Afin d\u2019obtenir une\u00a0Autorisation de Mise sur le March\u00e9 (AMM)\u00a0pour un m\u00e9dicament en France, un laboratoire pharmaceutique doit pr\u00e9senter un dossier aupr\u00e8s de l\u2019ANSM\u00a0pr\u00e9sentant notamment diff\u00e9rentes donn\u00e9es cliniques. Lorsqu\u2019un laboratoire pharmaceutique fran\u00e7ais ou \u00e9tranger souhaite obtenir une AMM pour un m\u00e9dicament g\u00e9n\u00e9rique, le dossier doit \u00e9galement comporter des \u00e9tudes de bio\u00e9quivalence avec le princeps. Retrouvez l&rsquo;article [&hellip;]<\/p>\n","protected":false},"author":18,"featured_media":3708,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[15],"tags":[],"class_list":["post-3707","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-publications"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.cvs-avocats.com\/fr\/wp-json\/wp\/v2\/posts\/3707","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cvs-avocats.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cvs-avocats.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cvs-avocats.com\/fr\/wp-json\/wp\/v2\/users\/18"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cvs-avocats.com\/fr\/wp-json\/wp\/v2\/comments?post=3707"}],"version-history":[{"count":0,"href":"https:\/\/www.cvs-avocats.com\/fr\/wp-json\/wp\/v2\/posts\/3707\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cvs-avocats.com\/fr\/wp-json\/wp\/v2\/media\/3708"}],"wp:attachment":[{"href":"https:\/\/www.cvs-avocats.com\/fr\/wp-json\/wp\/v2\/media?parent=3707"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cvs-avocats.com\/fr\/wp-json\/wp\/v2\/categories?post=3707"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cvs-avocats.com\/fr\/wp-json\/wp\/v2\/tags?post=3707"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}